Health · category
Medicine
- 1ME sufferers betrayed by decades of medical dismissal●Abandoned, dismissed and gaslighted: there is no excuse for the way ME sufferers have been betrayed
Guardian columnist George Monbiot argues that people with myalgic encephalomyelitis have been abandoned, dismissed and gaslighted by the medical establishment. Despite changes in official guidance and growing scientific understanding, millions of patients continue to see little improvement in their lives. He calls it a social crisis playing out behind closed doors and says there is no excuse for the way sufferers have been betrayed.
- 2Federal bill targets corporate ownership of medical practices●Federal bill proposes banning the corporate practice of medicine nationwide
A new federal bill has been introduced proposing a nationwide ban on the corporate practice of medicine, which would bar corporations from owning or controlling medical practices. Law firm analysis notes the proposal could have wide-reaching effects on health care businesses, private equity investors and physician groups that rely on corporate structures.
- 3
Stanford Medicine has put forward the claim that the human brain is not one organ but two, according to a report shared by KRON 4. The announcement is drawing wide attention, with hundreds of thousands of people engaging with the story. Details of the research, its methods and its implications for neuroscience and medicine have not been made clear in early coverage, leaving many questions about what the finding actually means.
- 4
This is a news story from the Financial Times reporting that medicines are running short in Iran under US sanctions. Based on the single headline available, it appears to describe shortages of pharmaceutical supplies affecting Iranians, with sanctions reportedly contributing to the problem. The evidence consists only of the headline, so the specific details, affected medicines, or responses are not clear from the posts. Readers commenting on such stories typically discuss humanitarian impacts of sanctions.
- 5Insilico Medicine signs multimillion AI drug discovery deal●Insilico Medicine strikes tens-of-millions AI co-development deal with unnamed foundation-model lab
Insilico Medicine, the Hong Kong-based clinical-stage biotech known for using generative AI in drug discovery, has struck a co-development deal worth tens of millions of dollars with an unnamed foundation-model laboratory. The partnership will focus on building AI models for drug development. The identity of the partner lab has not been disclosed.